Novel diabetes autoantibodies and prediction of type 1 diabetes

Current Diabetes Reports

Volumn 13, Issue 5, 2013, Pages 608-615

  Wenzlau, Janet M ^a   Hutton, John C ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Autoantibody; Autoantigen; Type 1 diabetes; Zinc transporter 8

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE; MEMBRANE PROTEIN;

ALTERNATIVE RNA SPLICING; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; DISEASE COURSE; GENETIC RISK; HUMAN; HUMORAL IMMUNITY; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PREVALENCE; RADIOIMMUNOASSAY; SECONDARY PREVENTION; T LYMPHOCYTE;

AUTOANTIBODIES; AUTOANTIGENS; CATION TRANSPORT PROTEINS; DIABETES MELLITUS, TYPE 1; HUMANS; RADIOIMMUNOASSAY;

EID: 84884589209     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0405-9     Document Type: Article

References (47)

1. Rosmalen JG, van Ewijk W, Leenen PJ. T-cell education in autoimmune diabetes: teachers and students. Trends Immunol. 2002;23(1):40-6.
2. Pihoker C, Gilliam l, Hampe C, Lernmark A. Autoantibodies in diabetes. Diabetes. 2005;54:S52-61.
3. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986;314(21):1360-8.
4. Oling V, Marttila J, Ilonen J, Kwok WW, Nepom G, Knip M, et al. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J Autoimmun. 2005;25(3):235-43.
5. Kelemen K, Gottlieb PA, Putnam AL, Davidson HW, Wegmann DR, Hutton JC: HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes. J. Immunol. 2004;172(6):3955-62.
6. Pietropaolo M, Towns R, Eisenbarth GS: Humoral autoimmunity in type 1 diabetes: prediction, significance, and detection of distinct disease subtypes. Cold Spring Harb Perspect Med. 2012. doi: 10.1101/cshperspect.a012831
7. Arvan P, Pietropaolo M, Ostrov D, Rhodes CJ: Islet autoantigens: structure, function, localization, and regulation. Cold Spring Harb Perspect Med. 2012. doi: 10.1101/cshperspect.a007658
8. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol. 2009;5(4):219-26.
9. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol. 1995;155(11):5419-26.
10. Chimienti F, Favier A, Seve M. ZnT-8, a pancreatic beta-cell-specific zinc transporter. Biometals. 2005;18(4):313-7.
11. Chimienti F, Devergnas S, Pattou F, Schuit F, Garcia-Cuenca R, Vandewalle B, et al. In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci. 2006;119(Pt 20):4199-206.
12. Wasmeier C, Hutton JC. Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes. J Biol Chem. 1996;271(30):18161-70.
13. Christgau S, Aanstoot HJ, Schierbeck H, Begley K, Tullin S, Hejnaes K, et al. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain. J Cell Biol. 1992;118(2):309-20.
14. Kutlu B, Burdick D, Baxter D, Rasschaert J, Flamez D, Eizirik DL, et al. Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics. 2009;2:3.
15. Mziaut H, Trajkovski M, Kersting S, Ehninger A, Altkrüger A, Lemaitre RP, et al. Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5. Nat Cell Biol. 2006;8(5):435-45.
16. Diez J, Park Y, Zeller M, Brown D, Garza D, Ricordi C, et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes. 2001;50(4):895-900.
17. Wang C, Mao R, Van de Casteele M, Pipeleers D, Ling Z. Glucagon-like peptide-1 stimulates GABA formation by pancreatic beta-cells at the level of glutamate decarboxylase. Am J Physiol Endocrinol Metab. 2007;292(4):E1201-6.
18. Tamaki M, Fujitani Y, Uchida T, Hirose T, Kawamori R, Watada H. Downregulation of ZnT8 expression in pancreatic β-cells of diabetic mice. Islets. 2009;1(2):124-8.
19. Marchand L, Polychronakos C. Evaluation of polymorphic splicing in the mechanism of the association of the insulin gene with diabetes. Diabetes. 2007;56(3):709-13.
20. Diez J, Park Y, Zeller M, Brown D, Garza D, Ricordi C, et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes. 2001;50(4):895-900.
21. Liu H, Wang Z, Li S, Zhang Y, Yan YC, Li YP. Utilization of an intron located polyadenlyation site resulted in four novel glutamate decarboxylase transcripts. Mol Biol Rep. 2009;36(6):1469-74.
22. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet. 1974;2(7892):1279-83.
23. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347(6289):151-6.
24. Hagopian WA, Michelsen B, Karlsen AE, Larsen F, Moody A, Grubin CE, et al. Autoantibodies in IDDM primarily recognize the 65,000-M(r) rather than the 67,000-M(r) isoform of glutamic acid decarboxylase. Diabetes. 1993;42(4):631-6.
25. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes. 1992;41(2):183-6.
26. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol. 1994;13(5):505-14.
27. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science. 1983;222(4630):1337-9.
28. Wenzlau JM, Sheridan L, and Hutton JC: Discovering Novel Antigens in Type 1 Diabetes. In Immunoendocrinology: Scientific and Clinical Aspects 2010, Book Chapter, Springer Publishing.
29. Astorri E, Guglielmi C, Bombardieri M, Alessandri C, Buzzetti R, Maggi D, et al. Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes. Horm Metab Res. 2010;42(13):955-60.
30. Li SW, Koya V, Li Y, Donelan W, Lin P, Reeves WH, et al. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes. Lab Invest. 2010;90(1):31-9.
31. Shehadeh N, Pollack S, Wildbaum G, Zohar Y, Shafat I, Makhoul R, et al. Selective autoantibody production against CCL3 is associated with human type 1 diabetes mellitus and serves as a novel biomarker for its diagnosis. Immunol. 2009;182(12):8104-9.
32. Huang G, Mo X, Li M, Xiang Y, Li X, Luo S, et al. Autoantibodies to CCL3 are of low sensitivity and specificity for the diagnosis of type 1 diabetes. Acta Diabetol. 2012;49(5):395-9.
33. Fierabracci A, Saura F. Identification of a common autoantigenic epitope of protein disulfide isomerase, golgin-160 and voltage-gated potassium channel in type 1 diabetes. Diabetes Res Clin Pract. 2010;88(2):e14-6.
34. Massa O, Alessio M, Russo L, Nardo G, Bonetto V, Bertuzzi F, et al. Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes. J Proteomics. 2013;82C:263-73.
35. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar S, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007;104:17040-5.
36. th Annual Meeting of the European Association for the Study of Diabetes (EASD), Vienna, Austria, Sept. 8-11, 2009.
37. Wenzlau JM, Liu Y, Yu L, Moua O, Fowler KT, Rangasamy S, et al. A Common Non-synonymous Single Nucleotide Polymorphism in the Slc30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes. Diabetes. 2008;57(10):2693-7. The study shows ZnT8 variant specific autoimmunity demonstrating a true immune response against self molecules.
38. Kordonouri O, Hartmann R, Charpentier N, Knip M, Danne T, Ilonen J. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany. Exp Clin Endocrinol Diabetes. 2010;118(4):245-9.
39. Brorsson C, Vaziri-Sani F, Bergholdt R, Eising S, Nilsson A, Svensson J, et al. Pociot F; Danish Study Group of Childhood Diabetes: Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes. Autoimmunity. 2011;44(2):107-14.
40. •• Yu L, Miao D, Scrimgeour L, Johnson K, Rewers M, Eisenbarth GS. Distinguishing persistent insulin autoantibodies with differential risk: nonradioactive bivalent proinsulin/insulin autoantibody assay. Diabetes. 2012;61(1):179-86. The paper documents firm establishment of a consistent, reliable and sensitive insulin autoantibody assay.
41. • Lampasona V, Schlosser M, Mueller PW, Williams AJ, Wenzlau JM, Hutton JC, et al. Diabetes antibody standardization program: first proficiency evaluation of assays for autoantibodies to zinc transporter 8. Clin Chem. 2011;57(12):1693-702. External validation of the ZnT8 RIA, leading to eventual implementation for clinical diagnosis of T1D.
42. Wenzlau JM, Walter M, Gardner TJ, Frisch LM, Yu L, Eisenbarth GS, et al. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab. 2010;95(10):4712-9.
43. Ungar B, Stocks AE, Martin FI, Whittingham S, Mackay IR. Intrinsic-factor antibody, parietal-cell antibody, and latent pernicious anaemia in diabetes mellitus. Lancet. 1968;2(7565):415-7.
44. Wenzlau JM, Gardner TJ, Frisch LM, Davidson HW, Hutton JC. Development of a novel autoantibody assay for autoimmune gastritis in type 1 diabetic individuals. Diabetes Metab Res Rev. 2010;27(8):887-90.
45. Maeda M. Gastric proton pump (H+/K(+)-ATPase): structure and gene regulation through GATA DNA-binding protein(s). J Biochem. 1994;115(1):6-14.
46. Shenkarev ZO, Lyukmanova EN, Butenko IO, Petrovskaya LE, Paramonov AS, Shulepko MA, et al. Lipid-protein nanodiscs promote in vitro folding of transmembrane domains of multi-helical and multimeric membrane proteins. Biochim Biophys Acta. 2013;1828(2):776-84.
47. Khan MW, Sherwani S, Khan WA, Ali R. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes. Autoimmunity. 2009;42(2):150-8.